Connecting you to content on EBSCOhost

Works by Kinneer, Krista

Results: 3

1

EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner.

Published in:

Cancer Biology & Therapy, 2012, v. 13, n. 8, p. 1, doi. 10.4161/cbt.20080

By:

Zhan Xiao;
Carrasco, Rosa A.;
Kinneer, Krista;
Sabol, Darrin;
Jallal, Bahija;
Coats, Steve;
Tice, David A.

Publication type:

Article

2

Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 12, p. 1789, doi. 10.1080/10428194.2024.2373331

By:

Dimopoulos, Meletios A.;
Migkou, Magdalini;
Bhutani, Manisha;
Ailawadhi, Sikander;
Kalff, Anna;
Walcott, Farzana L.;
Pore, Nabendu;
Brown, Miranda;
Wang, Fujun;
Cheng, Lily I.;
Kagiampakis, Ioannis;
Williams, Marna;
Kinneer, Krista;
Wu, Yuling;
Jiang, Yu;
Kubiak, Robert J.;
Zonder, Jeffrey A.;
Larsen, Jeremy;
Sirdesai, Shreerang;
Yee, Andrew J.

Publication type:

Article

3

MEDI2228, a novel BCMA pyrrolobenzodiazepine antibody drug conjugate, overcomes drug resistance and synergizes with bortezomib and DNA damage response inhibitors in multiple myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e154, doi. 10.1016/j.clml.2019.09.257

By:

Tai, Yu-Tzu;
Xing, Lijie;
Lin, Liang;
Yu, Tengteng;
Cho, Shih-Feng;
Wen, Kenneth;
Kinneer, Krista;
Munshi, Nikhil;
Anderson, Kenneth C.

Publication type:

Article